Myocardial protection in sepsis

Simon Shakar, Brian D. Lowes

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Sepsis with myocardial dysfunction is seen commonly. Beta-blockers have been used successfully to treat chronic heart failure based on the premise that chronically elevated adrenergic drive is detrimental to the myocardium. However, recent reports on the acute use of beta-blockers in situations with potential hemodynamic compromise have shown the risks associated with this approach. In critical situations, the main effect of adrenergic activation is to support cardiovascular function. Caution should be exercised in designing studies to assess beta-blockers in septic patients.

Original languageEnglish (US)
Article number177
JournalCritical Care
Volume12
Issue number5
DOIs
StatePublished - Sep 3 2008

Fingerprint

Adrenergic Agents
Sepsis
Myocardium
Heart Failure
Hemodynamics

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Myocardial protection in sepsis. / Shakar, Simon; Lowes, Brian D.

In: Critical Care, Vol. 12, No. 5, 177, 03.09.2008.

Research output: Contribution to journalArticle

Shakar, Simon ; Lowes, Brian D. / Myocardial protection in sepsis. In: Critical Care. 2008 ; Vol. 12, No. 5.
@article{2157c0a17f054769af818a53007dc007,
title = "Myocardial protection in sepsis",
abstract = "Sepsis with myocardial dysfunction is seen commonly. Beta-blockers have been used successfully to treat chronic heart failure based on the premise that chronically elevated adrenergic drive is detrimental to the myocardium. However, recent reports on the acute use of beta-blockers in situations with potential hemodynamic compromise have shown the risks associated with this approach. In critical situations, the main effect of adrenergic activation is to support cardiovascular function. Caution should be exercised in designing studies to assess beta-blockers in septic patients.",
author = "Simon Shakar and Lowes, {Brian D.}",
year = "2008",
month = "9",
day = "3",
doi = "10.1186/cc6978",
language = "English (US)",
volume = "12",
journal = "Critical Care",
issn = "1364-8535",
publisher = "BioMed Central Ltd.",
number = "5",

}

TY - JOUR

T1 - Myocardial protection in sepsis

AU - Shakar, Simon

AU - Lowes, Brian D.

PY - 2008/9/3

Y1 - 2008/9/3

N2 - Sepsis with myocardial dysfunction is seen commonly. Beta-blockers have been used successfully to treat chronic heart failure based on the premise that chronically elevated adrenergic drive is detrimental to the myocardium. However, recent reports on the acute use of beta-blockers in situations with potential hemodynamic compromise have shown the risks associated with this approach. In critical situations, the main effect of adrenergic activation is to support cardiovascular function. Caution should be exercised in designing studies to assess beta-blockers in septic patients.

AB - Sepsis with myocardial dysfunction is seen commonly. Beta-blockers have been used successfully to treat chronic heart failure based on the premise that chronically elevated adrenergic drive is detrimental to the myocardium. However, recent reports on the acute use of beta-blockers in situations with potential hemodynamic compromise have shown the risks associated with this approach. In critical situations, the main effect of adrenergic activation is to support cardiovascular function. Caution should be exercised in designing studies to assess beta-blockers in septic patients.

UR - http://www.scopus.com/inward/record.url?scp=68949207858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949207858&partnerID=8YFLogxK

U2 - 10.1186/cc6978

DO - 10.1186/cc6978

M3 - Article

C2 - 18828869

AN - SCOPUS:68949207858

VL - 12

JO - Critical Care

JF - Critical Care

SN - 1364-8535

IS - 5

M1 - 177

ER -